Mapping the prediction-invisible fraction of an engineered immunopeptidome: a pilot analysis of immunoproteasome-reprogrammed mesenchymal stromal cells
Algorithms that predict which peptides the immune system sees are central to cancer vaccine design, yet they are trained almost entirely on binding affinity and remain largely blind to how the antigen-processing machinery shapes the repertoire that rea…